Amylase
Amylase
Amylase
(CNP G3 Method)
For the determination of α-Amylase activity in serum, plasma or urine.
(For In vitro Diagnostic Use Only)
SUMMARY:
α-Amylase is most frequently measured in the diagnosis of acute pancreatitis when serum levels may be grossly
elevated and therefore is useful diagnostic tool in critical care management. In acute pancreatitis α-Amylase levels
reach a peak at 24 hours and remain elevated from 3-7 days. Hyperamylasemia is also associated with other acute
abdominal disorders, biliary tract diseases, diabetic ketoacidosis, severe glomerular dysfunction, salivary gland
disorders, and ruptured ectopic pregnancy.
PRINCIPLE:
Substrate CNP G3 is directly hydrolyzed by α-Amylase to produce CNP monitored at 405 nm during incubation of
the reagent with a sample.
α-Amylase
CNP G3 CNP + CNP G 2+ G 3+ G
CNP G3 = 2-Chloro-4-nitrophenyl-α-Maltotrioside
CNP G2 = 2-Chloro-4-nitrophenyl-α-Maltoside
CNP = 2-Chloro-4-nitrophenol
CONTENTS:
4x5ml 4x5ml
1x25ml 1x25ml
REAGENT PREPARATION:
SAMPLE MATERIAL:
Serum, heparinised plasma, urine.α-Amylase is reported to be stable in the sample for 5 days at 2–8ºC. Separate
serum from clot as soon as possible.
ASSAY PROCEDURE:
CALCULATIONS:
α-Amylase activity in IU/L (Serum) = ∆A/min. x 4640
NORMAL VALUE:
Serum upto 140 IU/L
LINEARITY:
The procedure is linear upto 2000 IU/L at 37OC. If the amylase activity is above 2000 IU/L, dilute the specimen
suitably with normal saline. In such case the results obtained should be multiplied by dilution factor to obtain
correct amylase activity.
NOTE:
Anticoagulants like Oxalate and EDTA bind Calcium, which is needed for α-Amylase activity and should not be
used. Heparin may be used. Saliva and sweat contain α-Amylase. Avoid contamination of reagent and sample
during use. Reagent should not be used if its absorbance exceeds 0.8 at 405 nm against distilled water.
REFERENCE: